Related references
Note: Only part of the references are listed.Lung Cancer Risk Associated with Regulated and Unregulated Chrysotile Asbestos Fibers
Ghassan B. Hamra et al.
EPIDEMIOLOGY (2017)
Highlights on immune checkpoint inhibitors in non-small cell lung cancer
Meng Shen et al.
TUMOR BIOLOGY (2017)
Drug combination approach to overcome resistance to EGFR tyrosine kinase inhibitors in lung cancer
Christy W. S. Tong et al.
CANCER LETTERS (2017)
Combined targeting of TGF-β, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model
Jesse Gore et al.
CANCER LETTERS (2016)
The necessity of and strategies for improving confidence in the accuracy of western blots
Rajeshwary Ghosh et al.
EXPERT REVIEW OF PROTEOMICS (2014)
Radiosensitization by combining an aurora kinase inhibitor with radiotherapy in hepatocellular carcinoma through cell cycle interruption
Zhong-Zhe Lin et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Silencing of JMJD2B induces cell apoptosis via mitochondria-mediated and death receptor-mediated pathway activation in colorectal cancer
Bei Bei Sun et al.
JOURNAL OF DIGESTIVE DISEASES (2014)
Disruption of STAT3 by Niclosamide Reverses Radioresistance of Human Lung Cancer
Shuo You et al.
MOLECULAR CANCER THERAPEUTICS (2014)
被撤回的出版物: MMP9 activation triggered by epidermal growth factor induced FoxO1 nuclear exclusion in non-small cell lung cancer (Retracted article. See April, 2017)
Jun Pei et al.
TUMOR BIOLOGY (2014)
Inflammatory cytokines and VEGF measured in exhaled breath condensate are correlated with tumor mass in non-small cell lung cancer
Luisa Brussino et al.
JOURNAL OF BREATH RESEARCH (2014)
Flow Cytometric Analysis of Macrophages and Dendritic Cell Subsets in the Mouse Lung
Alexander V. Misharin et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
P53 mutations in triple negative breast cancer upregulate endosomal recycling of epidermal growth factor receptor (EGFR) increasing its oncogenic potency
Iuliana Shapira et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Estrogen and insulin-like growth factor 1 synergistically promote the development of lung adenocarcinoma in mice
Hexiao Tang et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
N-Cadherin Expression Is Associated with Acquisition of EMT Phenotype and with Enhanced Invasion in Erlotinib-Resistant Lung Cancer Cell Lines
Xiaoju Zhang et al.
PLOS ONE (2013)
Silibinin Synergizes with Histone Deacetylase and DNA Methyltransferase Inhibitors in Upregulating E-cadherin Expression Together with Inhibition of Migration and Invasion of Human Non-small Cell Lung Cancer Cells
Samiha Mateen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Abstract 1886: Activation of IL-6R/JAK1/STAT3 signaling induces de novo resistance to irreversible EGFR inhibitors in non-small cell lung cancer with T790M resistance mutation
Byoung Chul Cho et al.
CANCER RESEARCH (2012)
Radiosensitizing Effect of a Phenylbutyrate-Derived Histone Deacetylase Inhibitor in Hepatocellular Carcinoma
Yen-Shen Lu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NFkB pathway in advanced-stage epithelial ovarian cancer
C. Alberti et al.
ONCOGENE (2012)
A Novel Classification of Lung Cancer into Molecular Subtypes
Lisandra West et al.
PLOS ONE (2012)
Manganese Induces IGF-1 and Cyclooxygenase-2 Gene Expressions in the Basal Hypothalamus during Prepubertal Female Development
Jill K. Hiney et al.
TOXICOLOGICAL SCIENCES (2011)
Combined tamoxifen and gefitinib in non-small cell lung cancer shows antiproliferative effects
Hua Shen et al.
BIOMEDICINE & PHARMACOTHERAPY (2010)
Gossypol inhibits phosphorylation of Bcl-2 in human leukemia HL-60 cells
Li-heng Huang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas
Sizhi Paul Gao et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression
Hania Wehbe et al.
CANCER RESEARCH (2006)
Share Paper
